![Jas Uppal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Jas Uppal worked as Director & Head-Global Emerging Markets at Biogen, Inc., Manager-Worldwide Regulatory Affairs at PAREXEL International Corp., and Chief Regulatory & Quality Officer at Gamida Cell Ltd. She also served as VP-Regulatory Affairs & Pharmacovigilance at Karyopharm Therapeutics, Inc. from 2015 to 2017 and as Vice President & Global Head-Regulatory Affairs at Ipsen Biopharmaceuticals, Inc. from 2017 to 2019.
Uppal holds a doctorate degree from King's College London and an undergraduate degree from Queen Mary University of London.
Former positions of Jas Uppal
| Companies | Position | End |
|---|---|---|
Ipsen Biopharmaceuticals, Inc.
 Ipsen Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Corporate Officer/Principal | 01/01/2019 |
| KARYOPHARM THERAPEUTICS INC. | General Counsel | 01/01/2017 |
| GAMIDA CELL LTD. | General Counsel | - |
| BIOGEN INC. | Director/Board Member | - |
| PAREXEL INTERNATIONAL CORPORATION | General Counsel | - |
Training of Jas Uppal
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gamida Cell Ltd.
 Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Queen Mary University of London
 Queen Mary University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ipsen Biopharmaceuticals, Inc.
Ipsen Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Jas Uppal
